Buenafe, Jin Irene S.

HRN: 24-02-60  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2024
CEFUROXIME 1.5GM (VIAL)
05/12/2024
05/18/2024
IV
1500mg
Every 8 Hours
LTCS
Waiting Final Action 
05/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/12/2024
05/18/2024
IV
500mg
Q8hrs
Stat CS
Waiting Final Action 
05/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/12/2024
05/18/2024
IV
500mg
Q8hrs
Stat CS
Waiting Final Action 
05/13/2024
METRONIDAZOLE 500MG (TAB)
05/13/2024
05/18/2024
ORAL
500mg
Every 8 Hours
Stat CS
Waiting Final Action 
05/13/2024
CEFUROXIME 500MG (TAB)
05/13/2024
05/17/2024
ORAL
500mg
2 Times A Day
Stat CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: